These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8057850)

  • 1. The porA gene in serogroup A meningococci: evolutionary stability and mechanism of genetic variation.
    Suker J; Feavers IM; Achtman M; Morelli G; Wang JF; Maiden MC
    Mol Microbiol; 1994 Apr; 12(2):253-65. PubMed ID: 8057850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Typing Neisseria meningitidis by analysis of restriction fragment length polymorphisms in the gene encoding the class 1 outer membrane protein: application to assessment of epidemics throughout the last 4 decades in China.
    Zhu P; Hu X; Xu L
    J Clin Microbiol; 1995 Feb; 33(2):458-62. PubMed ID: 7714207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence variation in the porA gene of a clone of Neisseria meningitidis during epidemic spread.
    Jelfs J; Munro R; Wedege E; Caugant DA
    Clin Diagn Lab Immunol; 2000 May; 7(3):390-5. PubMed ID: 10799451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The porA alleles are identical in subgroup III serogroup A Neisseria meningitidis strains isolated in China in the 1960s and 1980s.
    Malorny B; Maiden MC; Achtman M
    J Clin Microbiol; 1996 Jun; 34(6):1548-50. PubMed ID: 8735116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine.
    Martin SL; Borrow R; van der Ley P; Dawson M; Fox AJ; Cartwright KA
    Vaccine; 2000 May; 18(23):2476-81. PubMed ID: 10775781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between serological and sequencing analyses of the PorB outer membrane protein in the Neisseria meningitidis serotyping system.
    Sacchi CT; Lemos AP; Whitney AM; Solari CA; Brandt ME; Melles CE; Frasch CE; Mayer LW
    Clin Diagn Lab Immunol; 1998 May; 5(3):348-54. PubMed ID: 9605990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody recognition of members of the meningococcal P1.10 variable region family: implications for serological typing and vaccine design.
    Suker J; Feavers IM; Maiden MCJ
    Microbiology (Reading); 1996 Jan; 142 ( Pt 1)():63-69. PubMed ID: 8581171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic and/or phase variation of PorA protein in non-subtypable Neisseria meningitidis strains isolated in Spain.
    Alcalá B; Salcedo C; Arreaza L; Abad R; Enríquez R; De La Fuente L; Uría MJ; Vázquez JA
    J Med Microbiol; 2004 Jun; 53(Pt 6):515-518. PubMed ID: 15150331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proposed standardization of Neisseria meningitidis PorA variable-region typing nomenclature.
    Sacchi CT; Lemos AP; Brandt ME; Whitney AM; Melles CE; Solari CA; Frasch CE; Mayer LW
    Clin Diagn Lab Immunol; 1998 Nov; 5(6):845-55. PubMed ID: 9801347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States. The Active Bacterial Core Surveillance Team.
    Tondella ML; Popovic T; Rosenstein NE; Lake DB; Carlone GM; Mayer LW; Perkins BA
    J Clin Microbiol; 2000 Sep; 38(9):3323-8. PubMed ID: 10970378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deduced amino acid sequences of class 1 protein (PorA) from three strains of Neisseria meningitidis. Synthetic peptides define the epitopes responsible for serosubtype specificity.
    McGuinness B; Barlow AK; Clarke IN; Farley JE; Anilionis A; Poolman JT; Heckels JE
    J Exp Med; 1990 Jun; 171(6):1871-82. PubMed ID: 1693651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic variation of the class I outer membrane protein in hyperendemic Neisseria meningitidis strains in the netherlands.
    Bart A; Dankert J; van der Ende A
    Infect Immun; 1999 Aug; 67(8):3842-6. PubMed ID: 10417147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic shift and increased incidence of meningococcal disease.
    Harrison LH; Jolley KA; Shutt KA; Marsh JW; O'Leary M; Sanza LT; Maiden MC;
    J Infect Dis; 2006 May; 193(9):1266-74. PubMed ID: 16586364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of PorA variable region 3 in meningococci: implications for vaccine policy?
    Clarke SC; Diggle MA; Mölling P; Unemo M; Olcén P
    Vaccine; 2003 Jun; 21(19-20):2468-73. PubMed ID: 12744880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of hyperinvasive meningococcal strain types during global spread as recorded in the PubMLST database.
    Watkins ER; Maiden MC
    PLoS One; 2012; 7(9):e45349. PubMed ID: 23028953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diversity and prevalence of PorA types in Neisseria meningitidis serogroup B in the United States, 1992-1998.
    Sacchi CT; Whitney AM; Popovic T; Beall DS; Reeves MW; Plikaytis BD; Rosenstein NE; Perkins BA; Tondella ML; Mayer LW
    J Infect Dis; 2000 Oct; 182(4):1169-76. PubMed ID: 10979914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemic spread and antigenic variability of Neisseria meningitidis.
    Achtman M
    Trends Microbiol; 1995 May; 3(5):186-92. PubMed ID: 7627456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population genetic and evolutionary approaches to analysis of Neisseria meningitidis isolates belonging to the ET-5 complex.
    Bygraves JA; Urwin R; Fox AJ; Gray SJ; Russell JE; Feavers IM; Maiden MC
    J Bacteriol; 1999 Sep; 181(18):5551-6. PubMed ID: 10482493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of genosubtypes (PorA types) of serogroup B invasive meningococcus in the north of Spain from 2000 to 2003.
    Vicente D; Esnal O; Michaus L; López de Goicoechea MJ; Cisterna R; Pérez-Trallero E
    J Med Microbiol; 2005 Apr; 54(Pt 4):381-384. PubMed ID: 15770024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of transformation to construct antigenic hybrids of the class 1 outer membrane protein in Neisseria meningitidis.
    van der Ley P; van der Biezen J; Hohenstein P; Peeters C; Poolman JT
    Infect Immun; 1993 Oct; 61(10):4217-24. PubMed ID: 7691745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.